Lonza | LONN - Current Liabilities


Lonza reported CHF3.57B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.37B 56M Sep/2026
Alcon AG USD 3.17B 163M Jun/2026
Almirall EUR 323.65M 26.99M Jun/2026
AstraZeneca USD 31.27B 286M Sep/2026
BASF EUR 18.29B 2.62B Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Beiersdorf EUR 3.72B 209M Jun/2026
Covestro EUR 3.66B 204M Jun/2026
Demant DKK 12.42B 5B Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
Geberit CHF 854.7M 192.6M Dec/2024
Genmab DKK 1.14B 38M Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 20.72B 814M Sep/2026
GN Store Nord DKK 10.82B 4.86B Sep/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Merck EUR 8.96B 833M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Philips EUR 7.91B 485M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
Sika AG CHF 3.53B 730M Dec/2025
Smith & Nephew USD 2.05B 510M Jun/2026
Solvay EUR 1.82B 36M Sep/2026
UCB EUR 4.4B 470M Dec/2025